Physician profile
Michael Chu
NPI 1154718815
$7,154.96
in general payments reported to CMS, 2019-2025
14 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,666 · 2020: $2,938 · 2023: $168 · 2024: $258 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $551.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $550.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $4,979.33 | 2019-2020 | |
| Boston Scientific Corporation | $1,055.42 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Stryker Corporation | $207.97 | 2019 | |
| Avanos Medical | $198.30 | 2020-2023 | Standard Rf Disposables |
| Nevro Corp. | $133.75 | 2024 | Senza |
| Merz North America, INC. | $116.02 | 2019 | |
| Abbott Laboratories | $113.43 | 2019 | |
| Stimwave Technologies Incorporated | $86.89 | 2020 | |
| Abbvie INC. | $85.83 | 2024-2025 | |
| Azurity Pharmaceuticals, INC. | $63.83 | 2024 | Horizant |
| Nalu Medical, INC. | $44.75 | 2024 | Nalu Neurostimulation System |
| Csl Behring | $33.58 | 2025 | Hizentra |
| Ucb, INC. | $20.46 | 2025 | Briviact |
| Smith+Nephew, INC. | $15.40 | 2023 | Grafix Pl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Chu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.